Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Tricyclic antidepressant, the classic medicine for OCD. | Low-dose tablet for nerve pain, migraine and sleep. |
| Body system | Mental Health | Mental Health |
| Drug class | Tricyclic antidepressants | Tricyclic antidepressants |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Obsessive-compulsive disorder, Depression, Panic disorder, Cataplexy in narcolepsy (specialist) | Nerve pain, Migraine and tension headache prevention, Irritable bowel syndrome (low dose), Depression (higher dose) |
| How it works | Raises serotonin and noradrenaline levels in the brain. | Damps down pain signals and promotes sleep. |
| Starts working | 2–4 weeks (OCD up to 12 weeks) | — |
| Half-life | About 20–40 hours | 10–28 hours (metabolite nortriptyline longer) |
| Typical adult dose | 25 mg a day at first, increased to 100–150 mg a day (up to 250 mg for OCD). | Pain: 10 mg at night, increased slowly to 25–75 mg. Depression: 75–150 mg. |
| Forms | Capsule, Modified-release tablet | Tablet, Oral solution |
| Common side effects | Dry mouth, Constipation, Sweating, Drowsiness, Weight gain | Drowsiness, Dry mouth, Constipation, Weight gain, Blurred vision |
| Serious side effects | Seizures, Heart rhythm problems, Serotonin syndrome, Suicidal thoughts in young people | Abnormal heart rhythms, Urinary retention, Confusion in older people, Fatal in overdose |
| Don't take if | Recent heart attack; Heart block; Taking an MAOI; Uncontrolled epilepsy | Recent heart attack or arrhythmias; Taking an MAOI or within 14 days; Narrow-angle glaucoma or urinary retention; Mania |
| Alcohol | Best avoided. Alcohol increases drowsiness and the risk in overdose. | Best avoided. Alcohol adds strongly to drowsiness and overdose risk. |
| Pregnancy | Use with cautionUsed if clearly needed; newborn withdrawal symptoms are possible. | Use with cautionUsed when needed. |
| Breastfeeding | Use with cautionPasses into milk; the baby is watched for drowsiness. | Use with cautionSmall amounts in milk; low doses are usually acceptable. |
| In use since | — | 1961 |
| Brand names | United States: AnafranilUnited Kingdom: AnafranilIndia: Clofranil, Anafranil | United Kingdom: Triptafen (with perphenazine)India: Tryptomer, AmitoneAustralia: Endep |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | N06AA04 | N06AA09 |
Taken together
- ModerateClomipramine + Amitriptyline: Serotonin syndrome risk
Both medicines raise serotonin. Most combinations are tolerated, but the risk of serotonin toxicity rises, particularly when starting or increasing doses.
- ModerateClomipramine + Amitriptyline: Added sedation
Both medicines cause drowsiness; together they impair driving, balance and breathing, especially in older people.
- ModerateClomipramine + Amitriptyline: Additive QT prolongation
Both medicines can lengthen the QT interval. The risk is higher with heart disease, low potassium or magnesium, older age and female sex.
- ModerateClomipramine + Amitriptyline: High anticholinergic burden
Adding anticholinergic drugs increases dry mouth, constipation, urinary retention, blurred vision and confusion — and in older people, falls and possibly dementia risk.